An interventional study of Therapist Guided Internet-CBT for antenatal depression and Therapist Guided Internet-CBT for antenatal depression and perinatal extra support. in Antenatal Depression, sponsored by Karolinska Institutet. Recruiting at 1 site in Sweden. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-25.
Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 42 studies in Depression by Karolinska Institutet — 8 open to participants now, 11 under way, none of them phase 3. Depression · Karolinska Institutet.
Among the 42 studies in Depression by Karolinska Institutet, this one is the 4th largest by planned enrollment of the 34 interventional ones that give a count, is one of 4 that started in 2021, is one of 31 with no phase, reaches primary completion later than 3 of the 10 other live ones, and was the 27th registered.
8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.
Browse Depression studies →8 of the 42 studies in Depression by Karolinska Institutet are open now, in 1 country. Recruiting first, the newest first:
Karolinska Institutet · Sites in Sweden
Ages 18+
Karolinska Institutet · Sites in Sweden
Ages 18+
Karolinska Institutet · Sites in Sweden
Ages 18+
Karolinska Institutet · Sites in Sweden
Ages 18+ · Healthy volunteers
Karolinska Institutet · Sites in Sweden
Ages 18+
By country, each count listing its studies:
Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
42 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 4 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 415 is above the median of 81 across 7,089 interventional studies indexed under Depression.
Median enrollment 130 across the 34 interventional studies, 140 across the 8 observational. Of the 31 that completed or were terminated, 1 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
Karolinska Institutet is the lead sponsor of 1,150 studies on the registry; 276 are open to participants now.
2 of the studies in Depression by Karolinska Institutet that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06145555Karolinska InstitutetAcute Psychological Sleep Stabilisation for Patients Hospitalised With Depression | 2026-12 |
| NCT06687291Karolinska InstitutetCognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer | 2027-11-11 |
Add all 2 to your calendar (.ics) → With an account.
Among the 42 studies in Depression by Karolinska Institutet, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Pregnant women in pregnancy week 8-29 screening positive for antenatal depression will be randomized to either choose or to be allotted by chance to different forms of diagnostic assessment; i.e. telephone, video or face-to-face assessment.
Those diagnosed with mild to moderate major depression will then be randomized to treatment with therapist-guided Internet-delivered Cognitive Behavioral Therapy (ICBT) adapted for women suffering from antenatal depression or to the same treatment with addition of up to three contacts with extra support by a midwife or experienced perinatal mental health nurse.
The primary aim is to assess whether extrasupport in addition to internet-guided pregnancy adapted ICBT decreases depressive symptoms more than internet-guided pregnancy adapted ICBT only. Secondary aims include effects of extrasupport and assessment mode on treatment satisfaction, fidelity and credibility.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients are randomized to assessment modality (telephone, video or face-to-face visit) of a perinatal psychiatric semi-structured assessment \& and are randomised to treatment with internet-CBT for antenatal depression without extra-support (10 weeks)
Behavioral: Therapist Guided Internet-CBT for antenatal depression · Behavioral: Diagnostic assessment by telephone, video or face-to face - Allocation by chance
Patients choose assessment modality (telephone, video or face-to-face visit) of a perinatal psychiatric semi-structured assessment \& are randomised to treatment with internet-CBT for antenatal depression without extra-support (10 weeks)
Behavioral: Therapist Guided Internet-CBT for antenatal depression · Behavioral: Diagnostic assessment by telephone, video or face-to face - Allocation by choice
Patients are randomized to assessment modality (telephone, video or face-to-face visit) of a perinatal psychiatric semi-structured assessment \& and are randomised to treatment with internet-CBT for antenatal depression with extra-support
Behavioral: Therapist Guided Internet-CBT for antenatal depression and perinatal extra support. · Behavioral: Diagnostic assessment by telephone, video or face-to face - Allocation by chance
Patients choose assessment modality (telephone, video or face-to-face visit) of a perinatal psychiatric semi-structured assessment \& are randomised to treatment with internet-CBT for antenatal depression with extra-support (10 weeks)
Behavioral: Therapist Guided Internet-CBT for antenatal depression and perinatal extra support. · Behavioral: Diagnostic assessment by telephone, video or face-to face - Allocation by choice
A 10 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet. Includes traditional CBT-methods for depression adapted for antenatal depression.
A 10 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet. Includes traditional CBT-methods for depression adapted for antenatal depression. Additionally, up to three supportive contacts with a midwife or perinatal mental health nurse to support ICBT treatment and adress general pregnancy related health problems.
Structured diagnostic perinatal psychiatric assessment of women screening positive for antenatal depression (pregnancy week 8-29) by telephone, video or in a face-to-face meeting. Assessment form allocation by chance.
Structured diagnostic perinatal psychiatric assessment of women screening positive for antenatal depression (pregnancy week 8-29) by telephone, video or in a face-to-face meeting. Assessment form allocation based on patient preference.
Change in Montgomery Asberg Depression Rating Scale, self-rating version (MADRS-S)
A 9-item self-rated measure of depression severity that also screens for suicidality (Montgomery \& Asberg, 1979). Scores range from 0 to 54 points with 13-19 points indicating mild depression, 20-34 points indicating moderate depression and 35-54 points indicating severe depression
Time frame: Baseline to post-treatment (10 weeks) and to 8-10 weeks post-partum
Change in Edinburgh Postnatal Depression Scale (EPDS)
Self-rated measure of antenatal depression (Cox, Holden \& Sagovsky, 1987) used for screening of perinatal depression and also as a severity measure. Scores range from 0 to 30 with 13 or more points being the cut off for depression during pregnancy. This scale is validated for Swedish pregnant women (Rubertsson et al., 2011).
Time frame: Baseline to post-treatment (10 weeks) and to 8-10 weeks post-partum
Remission of major depression (DSM-5)
Diagnostic assessment of major depression assessed by clinician in the same way as before treatment with the depression module of the SCID-I diagnostic interview based on DSM-5 (Spitzer et al., 1992).
Time frame: Post-treatment (10 weeks)
Remission of major depression (DSM-5)
Diagnostic assessment of major depression assessed by clinician in the same way as before treatment with the depression module of the SCID-I diagnostic interview based on DSM-5 (Spitzer et al., 1992).
Time frame: 8-10 weeks postpartum.
Change in Generalized Anxiety Disorder-7 (GAD-7)
7-item self-assessment measure of symptoms of anxiety and worry (Spitzer et al., 2006). Scores range from 0 to 21 points with 10 points and above indicating clinical levels.
Time frame: Screening to post-treatment (10 weeks) and to 8-10 weeks post-partum
Change in self-rated Insomnia Severity Index (ISI)
7-item, self-rated questionnaire measuring perceived severity of insomnia symptoms (Bastien, Vallières \& Morin, 2001). Validated as an outcome measure for insomnia research. The scale includes seven items, scored on a 0-4 scale, that are summed to a range of 0-28. The score can be divided into four categories: no clinical insomnia (0-7), subthreshold insomnia (8-14), clinical insomnia of moderate severity (15-21) and severe clinical insomnia (22-28) (Sarsour et al., 2010).
Time frame: Baseline to post-treatment (10 weeks) and to 8-10 weeks post-partum
Change in Work and Social Adjustment Scale (WSAS)
Self-rated measure of level of impairment caused by a condition (Mundt et al. 2002). In this study two versions are used asking about impairment due to depression and due to pregnancy. Scores range from 0 to 40 with scores below 10 points indicating sub clinical impairment and scores above 20 indicating moderately severe impairment or worse.
Time frame: Baseline to post-treatment (10 weeks) and to 8-10 weeks post-partum
Change in Euroqol (EQ-5D-5L)
Self-assessed, health related, quality of life questionnaire. 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression (Hinz et al., 2014).
Time frame: Screening to post-treatment (10 weeks) and to 8-10 weeks post-partum
Change in Prenatal Attachment Inventory (PAI)
Self-rated measurement of attachment and mentalisation from the mother to the unborn child (Muller 1993; Pallant et al., 2014). 21-items scored on a 1-4 scale.
Time frame: Screening to post-treatment (10 weeks)
Change in Experience of close relationships (ENR)
Self-reported measurement of adult attachment style (Brennon et al., 1998; Fraley et al., 2000; Strand \& Ståhl, 2008). 36 items scored on a 1-7 scale.
Time frame: Screening to 8-10 weeks post-partum
Change in Valentine Scale
7 item self-rated scale for measurement of satisfaction with the partner relationship (Burman et al., 2018). Range 0-21 with higher values indicating higher partner relationship satisfaction.
Time frame: Screening to 8-10 weeks post-partum
Change in Fear of birth scale (FOBS)
Self-assessment of fear and worry in relation to the approaching birth using two visual analogue scales (VAS)(Haines et al., 2015) with higher levels indicating increased fear and worry. Also used to assess fear and worry in relation to completed birth after delivery.
Time frame: Screening to post-treatment (after 10 weeks) and to 8-10 weeks post-partum
Change in Multidimensional Scale of Perceived Social Support (MSPSS)
Measures self-rated perceived social support (Zimet et al., 1988; Ekbäck et al., 2013). 12 items rated on a seven-point Likert-type response format (1 = very strongly disagree; 7 = very strongly agree). Range 12 to 84, with higher scores indicating higher perceived social support.
Time frame: Screening to 8-10 weeks post-partum
Change in Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry (TIC-P)
Measures healthcare consumption and productivity loss in patients with a psychiatric disorder (Bouwmans et al., 2013).
Time frame: Baseline to post-treatment (10 weeks) and to 8-10 weeks post-partum
Change in Clinical Global Impression Severity Scale (CGI-S)
7-item observer-rated scale that measures illness severity (CGI-S) (Guy 1976)
Time frame: Post-assessment and post treatment (after week 10).
Change in Clinical Global clinical global improvement (CGI-I)
7-item observer-rated scale that measures global improvement (CGI-I) (Guy 1976).
Time frame: Post-assessment and post treatment (after week 10).
Assessment of childbirth experience - The Childbirth experience scale (CEQ)
Measures the childbirth experience (Dencker et al., 2010) on a 22-item 4-point Likert scale assessing agreement with positive and negative statements ranging from 1 (Totally agree), 2 (Mostly agree), 3 (Mostly disagree) to 4 (Totally disagree).
Time frame: 8-10 weeks post-partum
Assessment of maternal bonding - Mother-to Infant-Bonding-Scale (S-MIBS)
Assesses maternal bonding with the infant during the postpartum period. Eight items ranging 0- 3 with higher values indicating more bonding challenges (Taylor et al. 2005, Morelius et al., 2020).
Time frame: 8-10 weeks post-partum
Assessment of Adverse events
Patient rated adverse events.
Time frame: Treatment week 2,4,6,8
Assessment of Adverse events
Patient rated adverse events.
Time frame: Post-treatment (10 weeks)
Assessment of Adverse events
Patient rated adverse events.
Time frame: 8-10 weeks post-partum
Assessment of Adverse events
Clinician rated adverse events.
Time frame: Post-treatment (10 weeks).
Assessment of treatment satisfaction - Client Satisfaction Questionnaire-8 (CSQ-8)
Measures self-rated satisfaction with treatment with scores from 8 to 32 where 8-13 indicates poor, 14-19 fair, 20-25 good and 26-32 excellent satisfaction (Attkisson and Zwick, 1982; Smith et al. 2014)
Time frame: Post-treatment (10 weeks)
Assessment of treatment satisfaction - Client Satisfaction Questionnaire-8 (CSQ-8)
Measures self-rated satisfaction with treatment with scores from 8 to 32 where 8-13 indicates poor, 14-19 fair, 20-25 good and 26-32 excellent satisfaction (Attkisson and Zwick, 1982; Smith et al. 2014)
Time frame: 8-10 weeks postpartum
Assessment of treatment credibility - Treatment Credibility Scale (TCS)
The Treatment Credibility Scale is a version of the credibility/expectancy questionnaire (Devilly and Borkovec, 2000) assessing how well the respondent thinks the treatment would work for similar problems. Scores range from 5 to 50.
Time frame: Treatment week 2
Assessment of treatment credibility - Treatment Credibility Scale (TCS)
The Treatment Credibility Scale is a version of the credibility/expectancy questionnaire (Devilly and Borkovec, 2000) assessing how well the respondent thinks the treatment would work for similar problems. Scores range from 5 to 50.
Time frame: Treatment week 4
Assessment of treatment fidelity
Clinician rated structured assessment with instrument developed at the clinic for internet psychiatry.
Time frame: Post-treatment (10 weeks)
Assessment of maternity health care, birth- and child related health and care outcomes - Swedish pregnancy and medical birth registers.
Register data from the Swedish pregnancy and Medical Birth registers regering data on demographic, material health care, delivery care and child related outcomes will be linked by means of the unique personal identification number.
Time frame: Pregnancy to 8-10 weeks postpartum
Assessment of empowerment
Patient rated empowerment rated with the 28-item "Empowerment Scale" (Rogers et al. 1997).
Time frame: Post-assessment, post treatment (after week 10) and 8-10 weeks postpartum
Started Feb 2021 (actual). Primary completion is estimated for Dec 2025, 58 months after the start.
Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 58 months is above that.
Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.